Gérald Marit
About
In The Last Decade
Gérald Marit
190 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Hematology 5.9k
- Molecular Biology 3.3k
- Oncology 3.3k
- Genetics 2.2k
- Pathology and Forensic Medicine 1.8k
Countries citing papers authored by Gérald Marit
This map shows the geographic impact of Gérald Marit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Marit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Marit more than expected).
Fields of papers citing papers by Gérald Marit
This network shows the impact of papers produced by Gérald Marit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Marit. The network helps show where Gérald Marit may publish in the future.
Co-authorship network of co-authors of Gérald Marit
This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Marit. A scholar is included among the top collaborators of Gérald Marit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Marit. Gérald Marit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 21 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 33 | |
| 6 | 298 | |
| 7 | Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte breakdown → | 1071 |
| 8 | 18 | |
| 9 | 468 | |
| 10 | 387 | |
| 11 | 22 | |
| 12 | 128 | |
| 13 | Intérêt du dosage sérique de l'antigène galactomannane par méthode ELISA chez les patients présentant un risque d'aspergillose invasive dans un service d'hématologie | 2 |
| 14 | 4 | |
| 15 | Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. | 42 |
| 16 | 42 | |
| 17 | [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]. | 1 |
| 18 | Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques. | 10 |
| 19 | Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique. | 8 |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.